Resolve Therapeutics Lands $2,000,000 Series A Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=cb3d6987-f8f0-4dcb-9cf8-9a35785c8e87&Preview=1
Date
5/17/2011
Company Name
Resolve Therapeutics
Mailing Address
5400 Carillon Point Kirkland, WA 98033
Company Description
Resolve Therapeutics is a privately held biotechnology company based in Seattle that is dedicated to helping patients with lupus through the development of RSLV-125, its novel targeted biologic therapy.
Website
http://www.resolvebio.com
Transaction Type
Venture Equity
Transaction Amount
$2,000,000
Transaction Round
Series A
Proceeds Purposes
We continue to make progress towards our goal of clinical proof-of-concept for our investigational lupus compound RSLV-125.
M&A Terms
Venture Investor
New Science Ventures
Venture Investor
Easton Capital